Interactive Interpreter

PHQ-2 Questions, Scoring & Cutoff ≥3

The PHQ-2 (Patient Health Questionnaire-2) is a 2-item self-report questionnaire that screens for depression by asking about depressed mood and anhedonia over the past 2 weeks. A score of 3 or more (range 0–6) indicates the need for full PHQ-9 evaluation.

For professional reference, research, and education only. Not for diagnosis or medical advice.

PHQ-2 Screening Result Interpreter

  • PHQ-2 Score Calculator

    Enter each of the 2 items (0–3) to total them and see the band. Items are numbered, not reproduced — enter them from the form in front of you. Scoring aid only; it does not diagnose.

    0 of 2 items entered — 2 still blank. The total can only rise, so treat the range as provisional.

    Item 1
    Item 2

    Each item scores 0–3.

  • Enter a total score to see its range.

  • 2 items (depressed mood, anhedonia), each scored 0–3 based on frequency in the past 2 weeks. Total range 0–6. A single cutoff of ≥3 identifies a positive screen.

    Total scoreInterpretation
    3+Positive screenScore ≥3 indicates a positive screen. Proceed to full PHQ-9 and clinical evaluation; ask directly about suicidal ideation. The PHQ-2 alone is not sufficient to diagnose depression.
    0–2Negative screenScore below 3 is a negative screen. The PHQ-2 has a high negative predictive value, though clinical judgment should guide further assessment when suspicion remains high.

    Kroenke K, Spitzer RL, Williams JBW. Med Care. 2003;41(11):1284–1292. Cutoff ≥3 identified as optimal screening threshold (sensitivity 83%, specificity 92% against structured clinical interview).

The PHQ-2 is a 2-item depression screener made up of the first two items of the PHQ-9. Totals run from 0 to 6, and a score of 3 or more is a positive screen that calls for the full PHQ-9 1.

What does the PHQ-2 measure?

The PHQ-2 (Patient Health Questionnaire-2) asks how often, over the past 2 weeks, a person has been bothered by the two core symptoms of major depressive disorder: depressed mood and anhedonia (loss of interest or pleasure) 1. It can be used as a first step to identify who should complete the full PHQ-9 2.

Each item is rated 0–3 by frequency (not at all, several days, more than half the days, nearly every day), giving a total of 0–6. A score of 3 or higher is a positive screen and calls for the full PHQ-9 and a clinical evaluation.

The PHQ-2 is part of the PHQ family of questionnaires (PHQ-9, PHQ-A, PHQ-SADS) developed by Drs. Spitzer, Kroenke, and Williams.

The PHQ-2 is a gateway screen, not a standalone diagnosis

A positive PHQ-2 (≥3) requires follow-up with the full PHQ-9 and clinical evaluation. The PHQ-2 alone is not sufficient to diagnose depression or determine severity. It is designed as an efficient first step to identify who needs further assessment.

How do you give the PHQ-2?

Both questions ask about the past 2 weeks. Each is rated on a 4-point scale: 0 (Not at all), 1 (Several days), 2 (More than half the days), 3 (Nearly every day).

  • Anhedonia: Over the past 2 weeks, how often have you been bothered by little interest or pleasure in doing things?
  • Depressed mood: Over the past 2 weeks, how often have you been bothered by feeling down, depressed, or hopeless?

Administration best practices

  • Give it at intake and as a periodic check at follow-up visits
  • Proceed to the PHQ-9 promptly when the score is ≥3; do not defer to a later visit
  • Clients can complete it themselves (paper, tablet, or digital), saving clinician time
  • Always ask about suicidal ideation when the PHQ-2 is positive, regardless of PHQ-9 results

How do you score and interpret the PHQ-2?

The two item scores (0–3 each) are summed for a total of 0–6. A total of 3 or higher is a positive screen; the original study identified 3 as the optimal cutpoint for screening 1.

When the PHQ-2 is positive (≥3)

Required follow-up steps:

  • Give the full PHQ-9 (9 items) for severity scoring
  • Ask directly about suicidal ideation (PHQ-9 item 9)
  • Conduct a clinical interview to assess duration, impairment, and triggers
  • Consider the GAD-7 for co-occurring anxiety

A negative PHQ-2 does not rule out depression

At the ≥3 cutoff, pooled sensitivity was 72% 2, so some people with major depression screen negative. If clinical suspicion is high (e.g., the client reports sadness, sleep changes, or weight loss), give the full PHQ-9 regardless of the PHQ-2 score. Clinical judgment always supersedes a screening score.

Psychometric properties

In the original validation, 6,000 adults in 8 primary care and 7 obstetrics-gynecology clinics completed the PHQ-2. Functional status fell substantially as scores rose from 0 to 6. Against an independent structured mental health professional interview in 580 participants, a score of 3 or more had a sensitivity of 83% and a specificity of 92% for major depression 1.

At the ≥3 threshold:

  • Sensitivity: 83% in the original study 1; pooled 72% among studies using semistructured interviews in an individual participant data meta-analysis of 44,318 participants 2
  • Specificity: 92% in the original study 1; pooled 85% in the meta-analysis 2

A cutoff of 2 or more gave a pooled sensitivity of 91% and specificity of 67%, and the area under the ROC curve was 0.88 with semistructured interviews 2.

Limitations

  • Screening, not diagnosis. A positive PHQ-2 identifies who needs the full PHQ-9 and a clinical interview; it does not diagnose depression or measure severity.
  • Misses some cases. At the ≥3 cutoff, pooled sensitivity is 72%, so more than a quarter of people with major depression screen negative 2; use the full PHQ-9 when clinical suspicion is high.
  • Narrow content. It asks only about depressed mood and anhedonia, and it does not ask about suicidal ideation.
  • Self-report. Scores depend on the client's recall of the past 2 weeks and willingness to disclose.

PHQ-2 vs PHQ-9: when to use each

The PHQ-2 and PHQ-9 are designed to work together as a two-stage screening and assessment protocol.

  • Triage. In high-volume settings (primary care, urgent care, employee health), give the PHQ-2 to everyone; those who screen positive go on to the PHQ-9.
  • Less burden. In the meta-analysis, a PHQ-2 of 2 or more followed by a PHQ-9 of 10 or more had similar sensitivity to the PHQ-9 alone, slightly higher specificity, and would cut the number of people completing the full PHQ-9 by 57% 2.
  • The PHQ-9 alone. On its own, a PHQ-9 cut-off of 10 or more maximized combined sensitivity (88%) and specificity (85%) against semistructured interviews 3.
  • Monitoring. For measurement-based care focused on depression treatment, use the PHQ-9 directly at every visit rather than starting with the PHQ-2.

PHQ-2 scores belong in the Objective section of a SOAP note.

Billing the PHQ-2 (CPT 96127)

PHQ-2 administration qualifies for reimbursement under CPT code 96127 (brief emotional/behavioural assessment). Each unit represents one validated scale given, scored, and documented.

Medicare's Medically Unlikely Edit caps 96127 at 4 units per date of service; commercial payer limits vary, so confirm your contract. When the PHQ-2 is positive and you go on to the full PHQ-9, each scale can be billed as a separate 96127 unit in the same encounter.

For individuals: This page is a clinical reference, not a diagnostic tool. If you have concerns about your own symptoms, bring this information to a qualified mental health professional.

Measuring progress with clients?

  • HiBoop sends validated measures such as the PHQ-9 and GAD-7 by email or QR code, scores them on submission and charts each client's results over time.

Related

FAQ

  • What is a positive PHQ-2 score?

    A PHQ-2 score of 3 or higher is considered a positive screen for depression. This cutoff was identified as the optimal threshold in the original 2003 validation study by Kroenke et al., with a sensitivity of 83% and a specificity of 92% against a structured clinical interview. A positive result indicates the need for full PHQ-9 administration and clinical evaluation.

  • Can the PHQ-2 diagnose depression?

    No. The PHQ-2 is a screening tool, not a diagnostic test. A positive screen (≥3) identifies clients who need further evaluation with the full PHQ-9 and a clinical interview. Diagnosis of major depressive disorder requires a comprehensive clinical assessment that considers symptom duration, functional impairment, and differential diagnoses.

  • Is the PHQ-2 self-report or clinician-administered?

    The PHQ-2 is designed as a self-report questionnaire. Clients complete it on paper, tablet, or a digital form without clinician prompting, which makes it practical for routine intake screening in high-volume settings. Scores are then reviewed and acted upon by a clinician.

  • How is the PHQ-2 scored?

    Each of the two items is rated on a 4-point frequency scale: 0 (Not at all), 1 (Several days), 2 (More than half the days), and 3 (Nearly every day). The two item scores are summed for a total score ranging from 0 to 6. A total score of 3 or above is a positive screen.

References

    1. 1.Kroenke K, Spitzer RL, Williams JBW. The Patient Health Questionnaire-2: validity of a two-item depression screener. Med Care. 2003;41(11):1284-1292.
    2. 2.Levis B, Sun Y, He C, et al.; Depression Screening Data (DEPRESSD) PHQ Collaboration. Accuracy of the PHQ-2 Alone and in Combination With the PHQ-9 for Screening to Detect Major Depression: Systematic Review and Meta-analysis. JAMA. 2020;323(22):2290-2300.
    3. 3.Levis B, Benedetti A, Thombs BD. Accuracy of Patient Health Questionnaire-9 (PHQ-9) for screening to detect major depression: individual participant data meta-analysis. BMJ. 2019;365:l1476.
  • PHQ-2 © Pfizer Inc. No permission is required to reproduce, translate, display or distribute it.

HiBoop does not offer this scale. This page is reference material.

Start